Gene Profile May Help Identify Risk For Hormone-Sensitive, Hormone-Insensitive Breast Cancer
3/19/2013
Levels of 13 genes elevated in unaffected breasts of women with hormone receptor-negative breast cancer...
In Prostate Cancer, PCa Markers Improve Predictive Performance Of Existing Clinical Variables
3/19/2013
A genetic score based on PCa risk-associated single nucleotide polymorphisms (SNPs) is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China...
Incidence And Mortality Of PCa After Termination Of PSA-Based Screening
3/19/2013
Men who participate in biennial PSA based screening have a lower risk of being diagnosed as well as dying from prostate cancer up to 9 years after their last PSA test, according to the results of a new study presented at the 28th Annual EAU Congress in Milan A joint Swedish-UK study aimed to examined the risk of developing prostate cancer after last invitation to screening...
Lifestyle That Protects Heart May Also Reduce Cancer Risk
3/19/2013
A lifestyle that conforms to 7 steps recommended to protect against heart disease may also reduce risk of cancer, according to new research published online this week in the American Heart Association (AHA) journal Circulation...
Hormonal therapies can help control advanced prostate cancer for a time. However, for most men, at some point their prostate cancer eventually stops responding to further hormonal treatment. This stage of the disease is called androgen-insensitive or castration-resistant prostate cancer...
Epigenetic Changes Found To Play A Key Role In Development Of Chemo Resistance In Bladder Cancer
3/19/2013
At the 28th Annual EAU Congress W. Tan and colleagues presented their study on neoadjuvant cisplatin-based chemotherapy which showed that epigenetic changes are potential key drivers in the development of chemo resistance in bladder cancer. Neoadjuvant cisplatin-based chemotherapy is recommended for patients with muscle invasive bladder cancer...
Lymph Node And Distant Metastases Occur Even In Small Kidney Tumors, New Study Advocates Treatment
3/19/2013
Small kidney tumours have an agressive potential and should be treated, according to the results of a large multicentre study presented at the 28th Annual EAU Congress in Milan...
News From The Annals Of Family Medicine: March/April 2013
3/19/2013
False-Positive Mammography Results Cause Significant Long-Term Psychological Harm False-positive results are a common unintended harmful effect of breast cancer screening mammography - the cumulative risk in Europe and the United States of false positives in 10 screening rounds ranges from 20 to 60 percent - and they have long-term psychosocial consequences...
Newly identified mutations in a gene that makes cells immortal appear to play a pivotal role in three of the most common types of brain tumors, as well as cancers of the liver, tongue and urinary tract, according to research led by Duke Cancer Institute...
Further research also reveals quicker administration of Herceptin could save NHS £15m compared to current practice1 Results from the PrefHer (Patient Preference for Subcutaneous (SC) versus Intravenous (IV) Herceptin) trial show that 92% of early HER2-positive breast cancer patients favoured quicker SC administration of Herceptin compared to the standard IV infusion.1 Presented at the St...